{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:43:04Z","timestamp":1784824984959,"version":"3.55.0"},"reference-count":66,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To review the chemistry, pharmacology, and safety of fluoroquinolones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>A MEDLINE search (1966\u2013July 2007) was conducted using the key words fluoroquinolones or quinolones with safety, adverse effects, hypoglycemia. hyperglycemia, dysglycemia. QTc prolongation, torsades, seizures, phototoxicity, tendon rupture, Clostridium difficile, and pseudomembranous colitis for articles published in the English language.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection and Data Extraction:<\/jats:title>\n                    <jats:p>Medicinal chemistry, in vitro, animal, and human trials were reviewed for information on the chemistry, pharmacology, and safety of each fluoroquinolone. Clinical trials were reviewed and included to compare the safety of systemic fluoroquinolones on the market. Literature on the pathology of serious adverse effects was also reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Gatifloxacin has been shown to increase the risk of hospitalization for dysglycemia in patients with and without diabetes. Hyperglycemia may occur with any fluoroquinolone, especially if not properly dose adjusted. Hypoglycemia may occur with any fluoroquinolone and has a higher frequency in patients receiving concomitant oral hypoglycemic drugs or insulin. Use of any fluoroquinolone should be avoided in patients with risk factors for QTc interval prolongation or tendinopathy. All fluoroquinolones should be used with caution in patients with a history of seizure disorders and may cause phototoxicity or C. d\u00edfficile\u2013associated diarrhea (CDAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Clinicians should be aware of possible alterations in blood glucose, QTc interval prolongation, seizures, phototoxicity, tendinopathy, or CDAD with the use of any fluoroquinolone, especially in patients with other risk factors for these conditions. Clinicians should closely monitor for these adverse effects and appropriately adjust doses to minimize these risks. To provide safe treatment for patients needing antibiotic therapy, an assessment of the risk\u2013benefit ratio may be warranted in the decision to use a fluoroquinolone<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1k347","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T20:25:09Z","timestamp":1191356709000},"page":"1859-1866","source":"Crossref","is-referenced-by-count":165,"title":["Infectious Diseases: Safety Concerns with Fluoroquinolones"],"prefix":"10.1177","volume":"41","author":[{"given":"Allana J","family":"Mehlhorn","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Administration, Lloyd L Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana A","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Administration, Lloyd L Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2007,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.4.685"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013373435"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057838"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/428051"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70260-9"},{"key":"e_1_2_1_7_2","volume-title":"Factive (gemifloxacin)","author":"Package insert.","year":"2005","unstructured":"Package insert. Factive (gemifloxacin). Waltham, MA: Oscient Pharmaceuticals Corporation, August 2005."},{"key":"e_1_2_1_8_2","volume-title":"Levaquin (levofloxacin)","author":"Package insert.","year":"2007","unstructured":"Package insert. Levaquin (levofloxacin). Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., April 2007."},{"key":"e_1_2_1_9_2","volume-title":"Avelox (moxifloxacin)","author":"Package insert.","year":"2006","unstructured":"Package insert. Avelox (moxifloxacin). West Haven, CT: Bayer Pharmaceuticals Corporation, October 2006."},{"key":"e_1_2_1_10_2","volume-title":"Cipro (ciprofloxacin)","author":"Package insert.","year":"2005","unstructured":"Package insert. Cipro (ciprofloxacin). West Haven, CT: Bayer Pharmaceuticals Corporation, December 2005."},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.10.1291"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb02752.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.15.1825"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.10.1303"},{"key":"e_1_2_1_15_2","article-title":"Comparison of glucose intolerance between gatifloxacin and piperacillin\u2013tazobactam in elderly, hospitalized patients","author":"Lomaestro BM","year":"2004","unstructured":"Lomaestro BM, Lodise TP. Comparison of glucose intolerance between gatifloxacin and piperacillin\u2013tazobactam in elderly, hospitalized patients. Presented at: the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October 30-November 2, 2004.","journal-title":"Presented at: the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/61.23.2545"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.9.926.36093"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01158-0"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A480"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.16.5.455"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-12-200412210-00021"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2005.12.004"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/496929"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055191"},{"key":"e_1_2_1_25_2","unstructured":"Gatifloxacin (marketed as Tequin): information for healthcare professionals. Food and Drug Administration. www.fda.gov\/cder\/drug\/InfoSheets\/HCP\/gatifloxacinHCP.pdf (accessed 2007 May 23)."},{"key":"e_1_2_1_26_2","unstructured":"Drug shortages?\u2014discontinuations. Food and Drug Administration Centers for Biologics Evaluation and Research. www.fda.gov\/cder\/drug\/shortages\/TequinDiscontinuation2006.pdf (accessed 2007 May 23)."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.06.032"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.10.1296"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2000.108617"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120037431"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.17.1807.52348"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0788"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200606000-00009"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427090-00005"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg370"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032426"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.3.301.34206"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/428055"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.3.261.34200"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.1.122"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.20.1468.34482"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00009-2"},{"key":"e_1_2_1_43_2","unstructured":"FDA resources page. www.fda.gov\/ohrms\/dockets\/ac\/99\/slides\/3558sli.ppt (accessed 2007 Aug 6)."},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10359"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D349"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E587"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921050-00005"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.799-803.2004"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.suppl_2.67"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1086\/515104"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1086\/375078"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)45:3<235::AID-ART254>3.0.CO;2-7"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.15.1801"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2389"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl320"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp011603"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1086\/496986"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1086\/501954"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1086\/502539"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0906.020385"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl398"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.22.2518"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051639"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg115"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2006.26.1.61"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1086\/381551"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00592-06"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1K347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1K347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:08:35Z","timestamp":1777374515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1K347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":66,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1345\/aph.1K347"],"URL":"https:\/\/doi.org\/10.1345\/aph.1k347","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}